IR-Med Inc (IRME)
1.00
0.00 (0.00%)
USD |
OTCM |
May 31, 16:00
IR-Med SG&A Expense (Quarterly): 0.463M for March 31, 2024
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 0.463M |
December 31, 2023 | 0.627M |
September 30, 2023 | 0.728M |
June 30, 2023 | 0.604M |
March 31, 2023 | 0.747M |
December 31, 2022 | 1.399M |
September 30, 2022 | 0.408M |
June 30, 2022 | 0.559M |
Date | Value |
---|---|
March 31, 2022 | 0.376M |
December 31, 2021 | 0.381M |
September 30, 2021 | 0.348M |
June 30, 2021 | 1.125M |
March 31, 2021 | 0.327M |
December 31, 2020 | 0.171M |
September 30, 2020 | 0.034M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
0.034M
Minimum
Sep 2020
1.399M
Maximum
Dec 2022
0.5531M
Average
0.463M
Median
Mar 2024
SG&A Expense (Quarterly) Benchmarks
InspireMD Inc | 5.081M |
IDenta Corp | 0.1781M |
Holdco Nuvo Group DG Ltd | -- |
Pluri Inc | 2.511M |
BiomX Inc | 2.68M |